share_log

Shuttle Pharmaceuticals Has Been Granted European Patent Number EP3737376 Titled "Selective Histone Deacetylase Inhibitors For The Treatment Of Human Diseases (Including Cancers, Neurological Disorders, And Immunological Disorders)"

Shuttle Pharmaceuticals Has Been Granted European Patent Number EP3737376 Titled "Selective Histone Deacetylase Inhibitors For The Treatment Of Human Diseases (Including Cancers, Neurological Disorders, And Immunological Disorders)"

Shuttle Pharmicals 已獲得歐洲專利號 EP3737376,標題爲 “用於治療人類疾病(包括癌症、神經系統疾病和免疫系統疾病)的選擇性組蛋白脫乙酰酶抑制劑”
Benzinga ·  03/18 23:02

Shuttle Pharmaceuticals Has Been Granted European Patent Number EP3737376 Titled "Selective Histone Deacetylase Inhibitors For The Treatment Of Human Diseases (Including Cancers, Neurological Disorders, And Immunological Disorders)"

Shuttle Pharmicals 已獲得歐洲專利號 EP3737376,標題爲 “用於治療人類疾病(包括癌症、神經系統疾病和免疫系統疾病)的選擇性組蛋白脫乙酰酶抑制劑”

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論